Mostrando 2 resultados de: 2
Kaposi's Sarcoma and Human Herpesvirus 8 in Cuba: Evidence of subtype B expansion
ArticleAbstract: Objective: To evaluate the temporal distribution (1991-2009) and associated variation of KSHV subtypPalabras claves:Cuba, HHV-8, hiv, Kaposi sarcoma, KSHV subtypesAutores:Alemán-Campos Y., Álvarez A.A., Blanco O., Caballero I., Capó V., Cardellá L., Consuelo Beatriz Correa, Dovigny M.C., Fleites G., Hengge U.R., Jiménez N.A., Kourí-Cardellá V., Martínez P.A., Nambiar S., Pérez L., Rodríguez M.E., Soto-Brito Y.Fuentes:scopusSafety and immunogenicity of a human epidermal growth factor receptor 1 (HER1)-based vaccine in prostate castration-resistant carcinoma patients: A dose-escalation phase I study trial
ArticleAbstract: Metastatic castration-resistant prostate cancer (CRPC) remains incurable due to the lack of effectivPalabras claves:Human epidermal growth factor receptor, Immunogenicity, Prostate cancer, safety, Therapeutic vaccineAutores:Aira L.E., Bárbara Wilkinson, Caballero I., Casacó Parada A.R., Coba K., González J.G., González N., Lavastida A., Luaces P.L.o., Macías A.E., Mazorra Z., Mesa M., Popa X., Rivero J., Sanchez B., Santiesteban Y., Suárez E., Tania Crombet, Troche M.Fuentes:scopus